HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BR96-doxorubicin immunoconjugate

a chimeric monoclonal antibody, BR96 & doxorubicin immunoconjugate developed for the treatment of tumors that express Lewis(y)-related antigens
Also Known As:
BMS 182248; BMS-182248; SNG-15
Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Cardiotoxicity
3. Breast Neoplasms (Breast Cancer)
4. Adenocarcinoma of Lung

Related Drugs and Biologics

1. Doxorubicin (Adriamycin)
2. BR96-doxorubicin immunoconjugate
3. Immunoconjugates (Immunoconjugate)
4. Antigens